Description
Product Overview
SeamlessBio Newborn Calf Serum (NCS) — Australian Origin is collected from healthy bovine calves within the first 10 days of life at certified Australian collection facilities. Australia holds OIE negligible BSE/TSE risk status — no indigenous BSE case has ever been recorded — making this the highest-documented NCS available for regulated and semi-regulated workflows. Sterile filtered at 0.2 µm and batch-tested for endotoxin, haemoglobin, mycoplasma, and BVDV. EDQM Certificate of Eligibility (CEP) available.
NCS Australian Origin combines the immunological advantages of newborn serum — lower IgG than standard Calf Serum, marginally higher growth factor content — with the full BSE/TSE biosafety documentation of Australian origin. The preferred choice when lower immunoglobulin background and maximum regulatory traceability are both required, at 30–50% lower cost than FBS. See the full portfolio on our Newborn Calf Serum hub page.
Technical Specifications
| Parameter | Specification |
|---|---|
| Origin | Australia — certified collection facilities, OIE negligible BSE/TSE risk |
| Donor age | Calves ≤10 days of age (newborn) |
| BSE/TSE status | Negligible risk — OIE classification; no indigenous BSE ever detected in Australia |
| Regulatory documentation | EDQM CEP available |
| Filtration | 0.2 µm sterile filtered |
| Endotoxin | Tested per lot (LAL method) |
| Haemoglobin | ≤20 mg/dL |
| Mycoplasma | Negative (tested) |
| BVDV | Negative (tested) |
| Storage | –20 °C (cold chain required) |
| Options | Heat inactivated (56 °C, 30 min) on request |
| Documentation | CoA, CoO, SDS; EDQM CEP; TSE/BSE statement included |
| Formats | 50 mL, 100 mL, 500 mL; bulk on request |
| Regulatory | Research Use Only (RUO) |
NCS AUS vs. NCS US vs. FBS — Origin Comparison
| Property | NCS AUS Origin | NCS US Origin | FBS AUS Origin |
|---|---|---|---|
| BSE/TSE risk | Negligible (OIE) | Controlled (OIE) | Negligible (OIE) |
| Regulatory documentation | EDQM CEP available | USDA 9CFR CoA | EMEA-compliant, 0.1 µm |
| IgG content | Low | Low | Very low |
| Growth factors | Moderate–High | Moderate–High | Highest |
| Cost vs. FBS | 30–50% saving | 30–50% saving | Reference |
| Best for | Low IgG + max regulatory documentation | Low IgG, cost-sensitive research | Primary cells, ATMP, vaccine production |
Applications
| Application | Protocol | Note |
|---|---|---|
| Routine cell line maintenance | 5–10% NCS in DMEM, RPMI or MEM | CHO, HeLa, Vero, HEK293, BHK-21, MDCK — low IgG background with maximum BSE/TSE traceability |
| Immunoassay development | NCS as blocking agent or culture supplement | Lower IgG vs. standard CS reduces non-specific binding; EDQM CEP supports regulated assay validation |
| Veterinary vaccine production (non-ATMP) | 5–10% NCS in BHK-21, MDCK or Vero medium | OIE negligible BSE risk + EDQM CEP — cleanest regulatory path for licensed veterinary vaccine manufacturing |
| GMP-adjacent seed train | 5–10% NCS at N-2 to N-1 seed stages | Cost-optimised FBS alternative with full TSE/BSE documentation for regulated bioreactor processes |
| Large-scale cell banking | NCS in cryopreservation medium | Cost-efficient cryopreservation with EDQM CEP-backed documentation for master and working cell bank programmes |
Available Formats
| Format | Size |
|---|---|
| Bottle | 50 mL |
| Bottle | 100 mL |
| Bottle | 500 mL |
| Bulk | On request |
Key Benefits
Batch Reservation
Reserve validated lots up to 36 months for reproducible long-term workflows.
Full Documentation
CoA, EDQM CEP, TSE/BSE statement, CoO and SDS — from ISO 9001 and ISO 13485 certified partner facilities. Additional documents on request.
EU & Swiss Supply
Sourced from certified EU and Swiss partner facilities — fast cold-chain delivery across EU, UK and Switzerland.
Frequently Asked Questions
What makes Australian Origin NCS different from US Origin NCS?
Both NCS origins are collected from calves within the first 10 days of life and provide the same low IgG profile and moderate-to-high growth factor content. The difference lies in BSE/TSE documentation: Australian NCS comes from a country with OIE negligible BSE risk status — no indigenous BSE has ever been detected — and an EDQM Certificate of Eligibility (CEP) is available for EU regulatory submissions. US NCS (USDA 9CFR licensed) comes from a controlled-risk country. For research without regulatory requirements, both perform identically. For regulated manufacturing, veterinary vaccine production, or submissions requiring EDQM documentation, Australian origin is the preferred choice.
Can Australian NCS replace FBS in existing cell culture protocols?
For most standard immortalised cell lines (CHO, HeLa, Vero, HEK293, BHK-21, MDCK), NCS can be used as a drop-in FBS replacement at the same concentration (5–10%). A brief adaptation period of 2–3 passages is recommended to confirm growth kinetics and viability. NCS is not recommended for primary cells, stem cells, or applications that specifically require the high growth factor content of FBS.
What is the BSE/TSE status and what documentation is available?
Australia is classified by the OIE (World Organisation for Animal Health) as negligible BSE risk — no indigenous BSE has ever been recorded, and strict import controls on cattle and feed have been in place since the 1970s. An EDQM Certificate of Eligibility (CEP) is available, providing the highest level of BSE/TSE documentation accepted by the European Pharmacopoeia and EMA. A TSE/BSE risk assessment statement is included as standard with every lot. For applications requiring controlled-risk documentation at lower cost, see NCS US Origin.
Is heat inactivation available for Australian NCS?
Yes — heat inactivation (56 °C, 30 min) is available on request. Heat inactivation inactivates complement proteins and is recommended for complement-sensitive applications such as immunoassays and haematopoietic cell culture. Heat inactivation is documented in the lot CoA. Please specify at the time of enquiry.
What documentation is supplied with NCS Australian Origin?
Every order includes a Certificate of Analysis (CoA) and TSE/BSE risk assessment statement as standard. Additional documentation — EDQM CEP, Certificate of Origin (CoO), Safety Data Sheet (SDS), sterility certificate, and mycoplasma test protocol — is available on request. Products are handled at ISO 9001 and ISO 13485 certified partner facilities. Batch reservation for up to 36 months is available on request.
Request a Quote or Sample
48h response · EU & Swiss Supply · Batch reservation available · EDQM CEP available
English 
Deutsch